Ahmedabad-based Senores Pharma to use ₹107 cr from IPO proceeds for new unit in United States 0 19.12.2024 15:47 Thehindubusinessline.com Plans to invest a portion of the proceeds from ₹582 crore IPO for setting up a manufacturing facility for sterile injections at Atlanta in the United States Moscow.media Частные объявления сегодня Rss.plus Все новости за 24 часа
